OVID – Ovid Therapeutics Inc.
Ovid Therapeutics Inc.OVID
$2.79Name : Ovid Therapeutics Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $421,370,784.00
EPSttm : -0.23
Ovid Therapeutics Inc.
$2.79
1.45%$0.04
OVID — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
7.98
Margin Of Safety %
Put/Call OI Ratio
0.5
EPS Next Q Diff
-0.15
EPS Last/This Y
-0.19
EPS This/Next Y
-0.05
Price
2.8
Target Price
5.25
Analyst Recom
1
Performance Q
67.07
Upside
-221.1%
Beta
0.08
Ticker: OVID
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-17 | OVID | 2.015 | 0.08 | 7.84 | 4827 |
| 2026-03-18 | OVID | 2.295 | 0.07 | 0.25 | 4787 |
| 2026-03-19 | OVID | 2.295 | 0.10 | 1.07 | 5691 |
| 2026-03-20 | OVID | 2.615 | 0.18 | 0.02 | 6075 |
| 2026-03-23 | OVID | 2.54 | 0.20 | 0.66 | 5061 |
| 2026-03-24 | OVID | 2.4 | 0.24 | 1.09 | 5125 |
| 2026-03-25 | OVID | 2.39 | 0.24 | 0.16 | 5128 |
| 2026-03-26 | OVID | 2.45 | 0.24 | 0.00 | 5180 |
| 2026-03-27 | OVID | 2.29 | 0.24 | 1.11 | 5171 |
| 2026-03-30 | OVID | 2.11 | 0.24 | 106.78 | 5183 |
| 2026-03-31 | OVID | 2.21 | 0.46 | 0.00 | 6132 |
| 2026-04-01 | OVID | 2.16 | 0.44 | 0.92 | 6318 |
| 2026-04-02 | OVID | 2.2 | 0.45 | 0.96 | 6449 |
| 2026-04-06 | OVID | 2.32 | 0.48 | 0.01 | 6558 |
| 2026-04-07 | OVID | 2.56 | 0.46 | 0.01 | 6723 |
| 2026-04-08 | OVID | 2.62 | 0.47 | 0.03 | 6708 |
| 2026-04-09 | OVID | 2.88 | 0.46 | 0.02 | 6755 |
| 2026-04-10 | OVID | 2.75 | 0.48 | 1.27 | 6654 |
| 2026-04-13 | OVID | 2.8 | 0.50 | 0.08 | 6796 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-17 | OVID | 2.01 | 24.6 | -18.0 | -0.45 |
| 2026-03-18 | OVID | 2.33 | 24.6 | -26.3 | -0.45 |
| 2026-03-19 | OVID | 2.30 | 24.6 | -16.7 | -0.45 |
| 2026-03-20 | OVID | 2.62 | 24.6 | -24.4 | -0.45 |
| 2026-03-23 | OVID | 2.54 | 40.0 | -14.2 | -0.37 |
| 2026-03-24 | OVID | 2.40 | 40.0 | -11.0 | -0.37 |
| 2026-03-25 | OVID | 2.39 | 40.0 | -14.1 | -0.37 |
| 2026-03-26 | OVID | 2.45 | 40.0 | -16.1 | -0.37 |
| 2026-03-27 | OVID | 2.30 | 40.0 | -10.0 | -0.37 |
| 2026-03-30 | OVID | 2.11 | 17.9 | -8.9 | -0.43 |
| 2026-03-31 | OVID | 2.21 | 17.9 | -17.9 | -0.43 |
| 2026-04-01 | OVID | 2.16 | 17.9 | -12.9 | -0.43 |
| 2026-04-02 | OVID | 2.20 | 17.9 | -15.7 | -0.43 |
| 2026-04-06 | OVID | 2.32 | 17.9 | -18.0 | -0.43 |
| 2026-04-07 | OVID | 2.57 | 17.9 | -21.8 | -0.43 |
| 2026-04-08 | OVID | 2.61 | 17.9 | -15.5 | -0.43 |
| 2026-04-09 | OVID | 2.88 | 17.9 | -21.6 | -0.43 |
| 2026-04-10 | OVID | 2.76 | 17.9 | -11.6 | -0.43 |
| 2026-04-13 | OVID | 2.80 | 24.3 | -15.6 | -0.42 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-17 | OVID | -0.14 | 14.16 | 4.41 |
| 2026-03-18 | OVID | -0.14 | 14.16 | 4.41 |
| 2026-03-19 | OVID | -0.14 | 14.16 | 4.41 |
| 2026-03-20 | OVID | -0.14 | 14.16 | 4.41 |
| 2026-03-23 | OVID | -0.14 | 11.98 | 4.35 |
| 2026-03-24 | OVID | -0.14 | 11.98 | 4.35 |
| 2026-03-25 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-03-26 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-03-27 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-03-30 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-03-31 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-04-01 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-04-02 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-04-06 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-04-07 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-04-08 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-04-09 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-04-10 | OVID | -0.14 | 11.98 | 4.66 |
| 2026-04-13 | OVID | -0.14 | 12.10 | 7.98 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.06
Avg. EPS Est. Current Quarter
-0.12
Avg. EPS Est. Next Quarter
-0.09
Insider Transactions
-0.14
Institutional Transactions
12.1
Beta
0.08
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
23
Growth Score
42
Sentiment Score
99
Actual DrawDown %
41.8
Max Drawdown 5-Year %
-94.3
Target Price
5.25
P/E
Forward P/E
PEG
P/S
50.75
P/B
2.78
P/Free Cash Flow
EPS
-0.26
Average EPS Est. Cur. Y
-0.42
EPS Next Y. (Est.)
-0.47
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-240.11
Relative Volume
1.15
Return on Equity vs Sector %
-40.7
Return on Equity vs Industry %
-24.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.04
EBIT Estimation
-15.6
◆
OVID
Healthcare
$2.79
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
67.4
Range 1M
73%
Sup Dist
3.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-114.1%
EPS NY
-19.4%
52W%
88.4%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+88.2% upside
Upside
+88.2%
Quality
23
Ovid Therapeutics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 23
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
OVID
Latest News
—
Caricamento notizie per OVID…
stock quote shares OVID – Ovid Therapeutics Inc. Stock Price stock today
news today OVID – Ovid Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OVID – Ovid Therapeutics Inc. yahoo finance google finance
stock history OVID – Ovid Therapeutics Inc. invest stock market
stock prices OVID premarket after hours
ticker OVID fair value insiders trading